QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, March 24, 2004, 24(12):3051-3059; doi:10.1523/JNEUROSCI.4056-03.2004

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (44) Citing Articles via Google Scholar Google Scholar Articles by Richichi, C. Articles by Vezzani, A. Search for Related Content PubMed PubMed Citation Articles by Richichi, C. Articles by Vezzani, A.

 Previous Article  |  Next Article 

Neurobiology of Disease
Anticonvulsant and Antiepileptogenic Effects Mediated by Adeno-Associated Virus Vector Neuropeptide Y Expression in the Rat Hippocampus

Cristina Richichi,^1 * En-Ju D. Lin,^2 * Daniela Stefanin,¹ Daniele Colella,¹ Teresa Ravizza,¹ Giuliano Grignaschi,¹ Pietro Veglianese,¹ Günther Sperk,³ Matthew J. During,² and Annamaria Vezzani¹

¹Department of Neuroscience, Mario Negri Institute for Pharmacological Research, 20157 Milan, Italy, ²Department of Molecular Medicine, The University of Auckland, Auckland 1020, New Zealand, and ³Department of Pharmacology, University of Innsbruck, 6020 Innsbruck, Austria

Neuropeptide Y (NPY) inhibits seizures in experimental models and reduces excitability in human epileptic tissue. We studied the effect of long-lasting NPY overexpression in the rat hippocampus with local application of recombinant adeno-associated viral (AAV) vectors on acute kainate seizures and kindling epileptogenesis.

Transgene expression was significantly increased by 7 d, reached maximal expression by 2 weeks, and persisted for at least 3 months. Serotype 2 AAV vector increased NPY expression in hilar interneurons, whereas the chimeric serotype 1/2 vector caused far more widespread expression, also including mossy fibers, pyramidal cells, and the subiculum. EEG seizures induced by intrahippocampal kainate were reduced by 50–75%, depending on the vector serotype, and seizure onset was markedly delayed.

In rats injected with the chimeric serotype 1/2 vector, status epilepticus was abolished, and kindling acquisition was significantly delayed. Thus, targeted NPY gene transfer provides a potential therapeutic principle for the treatment of drug-resistant partial epilepsies.

Key words: epilepsy; fascia dentata; gene; kainic acid; kindling; seizure

---

Received Sep 3, 2003; revised January 19, 2004; accepted January 19, 2004.

This article has been cited by other articles:

				F. Noe, A.-H. Pool, J. Nissinen, M. Gobbi, R. Bland, M. Rizzi, C. Balducci, F. Ferraguti, G. Sperk, M. J. During, et al. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy Brain, June 1, 2008; 131(6): 1506 - 1515. [Abstract] [Full Text] [PDF]

				B. Tiesjema, R. A. H. Adan, M. C. M. Luijendijk, A. Kalsbeek, and S. E. la Fleur Differential Effects of Recombinant Adeno-Associated Virus-Mediated Neuropeptide Y Overexpression in the Hypothalamic Paraventricular Nucleus and Lateral Hypothalamus on Feeding Behavior J. Neurosci., December 19, 2007; 27(51): 14139 - 14146. [Abstract] [Full Text] [PDF]

				J. Veliskova and L. Velisek {beta}-Estradiol Increases Dentate Gyrus Inhibition in Female Rats via Augmentation of Hilar Neuropeptide Y J. Neurosci., May 30, 2007; 27(22): 6054 - 6063. [Abstract] [Full Text] [PDF]

				S. Lin, E.-J. D. Lin, D. Boey, N. J. Lee, K. Slack, M. J. During, A. Sainsbury, and H. Herzog Fasting Inhibits the Growth and Reproductive Axes via Distinct Y2 and Y4 Receptor-Mediated Pathways Endocrinology, May 1, 2007; 148(5): 2056 - 2065. [Abstract] [Full Text] [PDF]

				A. P. Silva, J. Lourenco, S. Xapelli, R. Ferreira, H. Kristiansen, D. P. D. Woldbye, C. R. Oliveira, and J. O. Malva Protein kinase C activity blocks neuropeptide Y-mediated inhibition of glutamate release and contributes to excitability of the hippocampus in status epilepticus FASEB J, March 1, 2007; 21(3): 671 - 681. [Abstract] [Full Text] [PDF]

				Y. H Raol, I. V Lund, S. Bandyopadhyay, G. Zhang, D. S Roberts, J. H Wolfe, S. J Russek, and A. R Brooks-Kayal Enhancing GABAA Receptor {alpha}1 Subunit Levels in Hippocampal Dentate Gyrus Inhibits Epilepsy Development in an Animal Model of Temporal Lobe Epilepsy. J. Neurosci., November 1, 2006; 26(44): 11342 - 11346. [Abstract] [Full Text] [PDF]

				E.-J. D. Lin, A. Sainsbury, N. J. Lee, D. Boey, M. Couzens, R. Enriquez, K. Slack, R. Bland, M. J. During, and H. Herzog Combined Deletion of Y1, Y2, and Y4 Receptors Prevents Hypothalamic Neuropeptide Y Overexpression-Induced Hyperinsulinemia despite Persistence of Hyperphagia and Obesity Endocrinology, November 1, 2006; 147(11): 5094 - 5101. [Abstract] [Full Text] [PDF]

				L. Ste. Marie, S. Luquet, T. B. Cole, and R. D. Palmiter Modulation of neuropeptide Y expression in adult mice does not affect feeding PNAS, December 20, 2005; 102(51): 18632 - 18637. [Abstract] [Full Text] [PDF]

				L. Costantin, Y. Bozzi, C. Richichi, A. Viegi, F. Antonucci, M. Funicello, M. Gobbi, T. Mennini, O. Rossetto, C. Montecucco, et al. Antiepileptic Effects of Botulinum Neurotoxin E J. Neurosci., February 23, 2005; 25(8): 1943 - 1951. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help